logo
Xenon Helps Four British Men Scale Mount Everest. Why Has It Caused Controversy?

Xenon Helps Four British Men Scale Mount Everest. Why Has It Caused Controversy?

News1823-05-2025
Last Updated:
The group, all former British special forces members, became the first climbers to use xenon gas to scale the world's highest mountain.
Climbing Mount Everest has always been seen as a test of endurance, patience and physical strength. But four British climbers recently made headlines for achieving the feat in just a few days using a gas that is not commonly associated with mountaineering.
The group, all former British special forces members, became the first climbers to use xenon gas to scale the world's highest mountain. The climbers included Alastair Carns, a parliament member and minister for veterans at the Defense Ministry along with Garth Miller, Anthony Stazicker and Kev Godlington. Their expedition, organised by Austria-based Furtenbach Adventures, reached the 8,848-metre summit in less than five days after leaving London.
While their achievement is notable, their use of xenon gas has stirred debate in the mountaineering community and triggered an official investigation in Nepal.
What Is Xenon Gas?
Xenon is a colourless and odourless gas that is over four and a half times heavier than air. It is found in tiny amounts in the Earth's atmosphere and is known for its use in medicine, especially as an anaesthetic.
The gas is also used in many other areas. According to CK Supply, it's found in projector and cinema lamps, camera flashes, car headlights, CT scans, satellites, deep space missions, nuclear energy and metallurgy.
Lukas Furtenbach, head of Furtenbach Adventures, told Reuters, 'Xenon improves acclimatisation and protects the body from altitude sickness and the effects from the hypoxic environment."
How Did The Climbers Use It?
The four British climbers inhaled xenon gas in Germany before beginning their expedition. They also trained at home using special tents that mimic high-altitude conditions. This pre-acclimatisation helped them avoid spending weeks on Everest adjusting to the low oxygen levels which is typically required.
During their actual climb, they still used supplemental oxygen like most mountaineers.
Furtenbach said the shorter expedition also helped reduce waste on the mountain. 'Less garbage, less resources, less human waste in this sensitive environment," he told Reuters.
Why Is The Use of Xenon Drawing Attention?
Nepal has started an investigation into the use of xenon gas by four British army veterans who recently climbed Mount Everest, according to The Kathmandu Post.
In a statement, Nepal's Department of Tourism said it had taken note of the media reports about the climbers' achievement. 'We are currently engaging with the expedition team leaders, members, and the associated agencies to gather detailed information and conduct a thorough study and analysis of this matter," it said.
What Are Experts Saying?
Peter Hackett, a mountaineering physician, told The Washington Post that xenon can temporarily increase erythropoietin (EPO), a hormone that stimulates red blood cell production. 'It did not increase red blood cells and it did not increase their exercise performance" in a study conducted on athletes, he said.
Dr Andrew Peacock, an altitude medicine expert at the University of Glasgow, also shared a similar view with BBC, saying, 'Increase in erythropoietin does nothing on its own. The question in this case is, does it really stimulate production of red blood cells in such a short period?"
The International Climbing and Mountaineering Federation (UIAA) also weighed in. 'According to current literature, there is no evidence that breathing in xenon improves performance in the mountains, and inappropriate use can be dangerous. Although a single inhalation of xenon can measurably increase the release of erythropoietin, this increase is not sustained over four weeks' use, nor is it associated with any changes in red blood cells. According to the literature, the effects on performance are unclear and probably non-existent," it said as quoted by BBC.
Ethical Concerns
The use of xenon isn't only raising health concerns, it has also started a debate about ethics and fairness in mountaineering. According to Reuters, American climber Adrian Ballinger called the method a 'stunt" and said, 'It's never seemed like the type of experience we want to provide." He added that using xenon makes the climb feel more like 'mountain tourism" than real mountaineering.
Ballinger also told the Washington Post, 'It is a banned substance by all professional sporting organisations, and even though [mountain climbing] is not managed by a sporting organisation, it's always been a goal of climbers to follow best practices of not doping. All that combined makes it feel, I guess, pretty icky. People should be able to climb how they want to, but it isn't mountain climbing; it's mountain tourism."
Damber Parajuli, president of the Expedition Operators Association of Nepal, told the BBC that shortcuts like this could damage the credibility of summit certificates and hurt the trekking industry.
First Published:
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What if AI did your health scan during next hospital visit? Is it safe? AIMS Delhi doctor raises concerns
What if AI did your health scan during next hospital visit? Is it safe? AIMS Delhi doctor raises concerns

Time of India

time4 hours ago

  • Time of India

What if AI did your health scan during next hospital visit? Is it safe? AIMS Delhi doctor raises concerns

AI in Radiology: A Double-Edged Sword Real-World Applications and Benefits MORE STORIES FOR YOU ✕ « Back to recommendation stories I don't want to see these stories because They are not relevant to me They disrupt the reading flow Others SUBMIT Training and Responsible Adoption Artificial intelligence (AI) is rapidly transforming healthcare, especially in medical analysis and radiology. Hospitals are increasingly adopting AI systems for patient triage, initial scans, and workflow optimization. While these technologies promise faster and more efficient diagnostics, experts warn that the rapid rollout carries significant to Dr. Datta of AIIMS Delhi, radiology is moving swiftly to agentic AI systems, which can independently perform complex tasks. While this shift offers the potential to improve diagnostic accuracy and reduce human workload, current evaluation frameworks are not robust enough. Regulators are still catching up, raising concerns about the safety of deploying AI tools that appear intelligent but have not been fully Datta emphasizes the need for a structured approach to evaluation: pre-deployment benchmarking and red-teaming, real-world testing in hospital information systems, and continuous monitoring post-deployment with uncertainty reporting. He also suggests developing task-specific metrics for radiology AI and a stage-wise evaluation framework for clinical, research, and educational studies highlight AI's potential in healthcare. In the UK, AI-assisted scans have been shown to reduce unnecessary X-rays and missed fractures. NICE, the country's health guidance body, considers these tools safe and reliable, potentially reducing follow-up appointments. Similarly, digital patient platforms like Huma can lower readmission rates by 30% and reduce the time clinicians spend reviewing patients by up to 40%, according to a World Economic Forum the US, standard large language models like ChatGPT have struggled to provide sufficiently evidence-based answers for clinicians. However, hybrid systems combining LLMs with retrieval-augmented methods have shown a significant improvement in providing useful the benefits, experts caution against uncritical adoption. Dr. Caroline Green of the University of Oxford stresses that healthcare professionals need proper training to understand AI limitations and mitigate risks, including errors in information or biased recommendations. Yorkshire-based studies also show that while AI can predict patient transfers accurately in many cases, careful implementation and additional training are essential before widespread use.

Student deaths spur BITS Goa to offer peer-support mental health programme
Student deaths spur BITS Goa to offer peer-support mental health programme

Time of India

time5 hours ago

  • Time of India

Student deaths spur BITS Goa to offer peer-support mental health programme

Panaji/Vasco: After the fourth student death in nine months was reported at the BITS Pilani K K Birla Goa campus last week, the institute said it will offer an 'emotional and social support' programme for youth. As part of the 'YESS' programme, the institute announced that select second- and fourth-year engineering and science students were trained over the course of four days by New Delhi-based non-profit mental health organisation, Rahat Charitable and Medical Research Trust, to offer peer-based support. 'It aims to empower students to recognise early signs of psychological distress, provide empathetic support, and connect peers with professional mental health resources,' the institute said in a statement. The 'YESS' programme, based on the principles of mental and emotional first aid (MEFA), is a peer-support initiative designed to address the rising mental health challenges faced by college students across India, BITS Pilani Goa campus said. It will be made operational from Sep. A 20-year-old third-year student from Uttar Pradesh, was found dead in his hostel room on campus last Saturday. While the cause of his death is yet to be confirmed, the first three cases were registered as death by suicide. In the first case, Om Priyan Singh, 21, a second-year BE computer science and MSc chemistry student from Uttar Pradesh, died by suicide in Dec 2024. The second case was in March 2025 relating to Atharv Desai, 20, a third-year dual degree student. In the third incident, 20-year-old student Krishna Kasera from Lucknow, a second-year student pursuing a dual degree in MSc chemistry and BE electrical and instrumentation, was reported to have died by suicide in May 2025. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.

Suneeta Reddy to sell 1.25% stake in Apollo Hospitals for ₹1,395 crore
Suneeta Reddy to sell 1.25% stake in Apollo Hospitals for ₹1,395 crore

Business Standard

time5 hours ago

  • Business Standard

Suneeta Reddy to sell 1.25% stake in Apollo Hospitals for ₹1,395 crore

Chennai-based Apollo Hospitals promoter and Managing Director Suneeta Reddy is likely to sell her 1.25 per cent stake in the company, valued at Rs 1,395 crore, through block deals, said sources familiar with the development. 'Reddy may sell 1.8 million shares in the company via block deals, at a floor price of Rs 7,747 per share,' said a source. Morgan Stanley has been appointed as the broker for the deal. Currently, Reddy holds a 3.36 per cent direct stake in Apollo Hospitals, valued at around Rs 3,828 crore based on the company's market capitalisation of Rs 1.14 trillion. Following the stake sale, her holding in Apollo will reduce to 2.11 per cent. This deal is priced at a 2 per cent discount to Thursday's closing price of Rs 7,925. Apollo Hospitals shares closed with gains of Rs 42, or 0.54 per cent. Her sisters, Preetha Reddy, Shobana Kamineni, and Sangita Reddy, hold 0.73 per cent, 1.56 per cent, and 1.69 per cent stakes, respectively, in the company. Interestingly, it was Suneeta Reddy who suggested the name 'Apollo' for her father, Prathap C Reddy's hospital chain back in 1983. Apollo Hospitals posted a 42 per cent rise in net profit during the first quarter of the financial year 2025-26, reaching Rs 432.8 crore, compared to Rs 305.2 crore in the April–June quarter of the previous financial year. The company's consolidated revenues grew 15 per cent year-on-year to Rs 5,842.1 crore, compared to Rs 5,085.6 crore in the January–March quarter of FY24. EBITDA stood at Rs 852 crore, up from Rs 675 crore in the first quarter of FY25. The profit rise was attributed to strong performances in Healthcare Services, Retail Healthcare and Diagnostics, as well as Digital and Pharma Distribution. As of 30 June, Apollo Hospitals had 8,030 operating beds across its network (excluding AHLL and managed beds), with an overall hospital occupancy rate of 65 per cent, compared to 68 per cent in the same period last year. During the quarter, the company announced an ambitious growth strategy to add over 4,300 beds in the next five years, with an investment of over Rs 7,600 crore. On the digital front, Apollo 24/7 achieved a quarterly GMV (gross merchandise value) of over Rs 682 crore, sustaining the platform's momentum and signalling strong ongoing demand for teleconsultations, lab services, and pharmacy deliveries.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store